T-cell surface glycoprotein CD5

BE0010434ProteinHumansCD5

Lymphoid-specific receptor expressed by all T-cells and in a subset of B-cells known as B1a cells. It is acted on by 1 drug in DrugBank.

Gene name
CD5
UniProtKB entry
P06127Swiss-Prot
Cellular location
Cell membrane
Residues / weight
495 residues · 54,578 Da
Also known as
LEU1 · Lymphocyte antigen T1/Leu-1

Resolves to

Protein
UniProtP06127UniProt nameCD5_HUMAN
Gene
HGNCHGNC:1685NCBI Gene921GeneCardsCD5
Pharmacology
KEGGhsa:921
Structure
PDB2JA4PDB2JOPPDB2JP0
Drugs

What you can answer from here — as of October 31, 2023

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
9Clinical trialsTrials of drugs acting on it, by phase and status
Sign in
1GO termFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which compounds in development act on T-cell surface glycoprotein CD5, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In